20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T7413 | JNJ-5207852 | Histamine Receptor | |
JNJ-5207852 is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor. | |||
T8822 | JNJ-5207852 dihydrochloride | Histamine Receptor | |
JNJ-5207852 dihydrochloride is a novel, non-imidazole histamine H3 receptor antagonist, with high affinity at the rat (pKi=8.9) and human (pKi=9.24) H3 receptor. | |||
T12612 | (R)-Apremilast | (R)-CC-10004 | Others |
(R)-Apremilast ((R)-CC-10004) is the enantiomer of Apremilast and one of the isoindoline derivatives. | |||
T16991 | Targapremir-210 | TGP-210 | Apoptosis |
Targapremir-210 (TGP-210) is a selective and potent miRNA-210 (miRNA-210) inhibitor that inhibits pre-miR-210 processing and induces apoptosis in breast cancer cells. | |||
T16730 | Remibrutinib | BTK | |
Remibrutinib inhibits BTK activity with an IC50 value of 0.023 μM in blood. Remibrutinib is an effective and orally active Bruton tyrosine kinase inhibitor (IC50: 1 nM). Remibrutinib has the potential for Chronic urticar... | |||
T23232 | Remoxipride hydrochloride | Remoxipride Hydrochloride Anhydrous,Roxiam,(S)-Remoxipride Hydrochloride | Dopamine Receptor |
Remoxipride hydrochloride (Roxiam) is a selective antagonist of D2 receptor with IC50s of 1.57 μM, >100 μM and 42 μM for D2 receptor, D1 receptor and α1-adrenoceptor. | |||
T5555 | Siremadlin | NVP-HDM 201 | E1/E2/E3 Enzyme |
Siremadlin (NVP-HDM 201) is a potent, orally bioavailable and highly specific p53-MDM2 interaction inhibitor. | |||
T77466 | Tremelimumab | Ticilimumab,CP-675206 | Others |
Tremelimumab is a cytotoxic T-lymphocyte-associated antigen-4 (CTLA-4) blocking antibody.Tremelimumab is often used in combination with Durvalumab for the treatment of solid cancers such as hepatocellular carcinoma and l... | |||
T36857L | Premarin | Estrone 3-sulfate,Estrone sulfate | Estrogen Receptor/ERR |
Premarin (Estrone 3-sulfate) is an an estrogen sulfate with neuroprotective actions during traumatic brain injury. | |||
T3499 | Remodelin | Histone Acetyltransferase | |
Remodelin is an effective and specific inhibitor of the acetyl-transferase protein NAT10. | |||
T12339 | Oxotremorine M iodide | Oxotremorine methiodide | AChR |
Oxotremorine M iodide (Oxotremorine methiodide) is an agonist of mAChR and potentiates NMDA receptors. | |||
T2923 | Apremilast | CC-10004 | Apoptosis , TNF , PDE |
Apremilast (CC-10004) (CC-10004) is a potent and orally active PDE4 (IC50=74 nM) with anti-inflammation activities. | |||
T6133 | Remodelin hydrobromide | Remodelin,Remodelin HBR | RAAS , Histone Acetyltransferase |
Remodelin hydrobromide (Remodelin HBR) is a novel potent and selective inhibitor of the acetyl-transferase protein NAT10. | |||
T7766 | Remdesivir | GS-5734 | SARS-CoV , DNA/RNA Synthesis |
Remdesivir (GS-5734) is a nucleoside analog, a broad-spectrum antiviral compound that exerts its activity by inhibiting the RNA-dependent RNA polymerase of viruses. Remdesivir is active against Ebola, SARS, and MERS viru... | |||
T2429 | Olverembatinib dimesylate | GZD824 Dimesylate,HQP1351 | Bcr-Abl |
Olverembatinib dimesylate (GZD824 Dimesylate) is a novel orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT) and Bcr-Abl(T315I). | |||
T16729 | Remetinostat | SHP-141 | HDAC |
Remetinostat (SHP-141), a hydroxamic acid-based inhibitor of histone deacetylase enzymes, is currently being developed for the treatment of cutaneous T-cell lymphoma. | |||
T34286 | Remogliflozin etabonate | GSK189075,GSK 189075,GSK-189075A,GSK189075A,GSK-189075,GSK 189075A | SGLT |
Remogliflozin etabonate (GSK189075A) is a prodrug of regaliflozin and an inhibitor SGLT2 with Ki values of 1.95, 2.14, 8.57, and 43.1μM for hSGLT2, rSGLT2, rSGLT1, and hSGLT1, respectively. | |||
T23116 | Oxotremorine sesquifumarate | AChR | |
Oxotremorine sesquifumarate is a muscarinic agonist. | |||
T3071 | Olverembatinib | GZD 824 | Bcr-Abl |
Olverembatinib (GZD 824) is an orally bioavailable Bcr-Abl inhibitor for Bcr-Abl(WT, IC50: 0.34 nM) and Bcr-Abl(T315I, IC50: 0.68 nM). | |||
T7608 | Bremelanotide Acetate | bremelanotide,PT-141 Acetate | Melanocortin Receptor |
Bremelanotide Acetate (PT-141 Acetate) is an agonist of melanocortin receptor (MCR) . |